Clinical Trial Update: The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the incidence of hepatitis B in HBsAg-positive patients with diffuse large B-cell lymphoma or chronic lymphocytic leukemia who are tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Vemlidy (tenofovir alafenamide)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Large-B-cell Diffuse Lymphoma, Chronic Lymphoid Leukemia | Phase 2 | Status: TERMINATED